文献速递泌尿生殖与妇科肿瘤放疗放疗物理与技术

FCH-PET/CT与mpMRI检测放疗后前列腺癌早期局部复发的比较

18F-Choline Positron Emission Tomography/Computed Tomography and Multiparametric Magnetic Resonance Imaging for the Detection of Early Local Recurrence of Prostate Cancer Initially Treated by Radiation Therapy: Comparison With Systematic 3-Dimensional Transperineal Mapping Biopsy.
PubMed 文献 · Int J Radiat Oncol Biol Phys · 2016-12-28

该回顾性单中心研究纳入32例疑似前列腺癌复发且已排除转移的患者,比较FCH-PET/CT、mpMRI及两者联合与3D经会阴系统穿刺活检对照的诊断性能。患者层面检出率mpMRI为71%、FCH-PET/CT为74%;分段层面两者敏感度均低(32%、34%)而特异度好(均87%),联合分析敏感度43%、特异度83%。结论认为两种影像敏感度有限,前列腺穿刺活检仍是诊断局部复发和筛选挽救治疗患者的必要手段。

要点

  • FCH-PET/CT与mpMRI对放疗后局部复发检出敏感度均低(分段32%–34%),特异度好(87%)。
  • 患者层面检出率mpMRI 71%、FCH-PET/CT 74%,两者联合分段准确率66%。
  • FCH-PET/CT观察者间一致性κ=0.92,高于mpMRI的κ=0.74。

核心结论

  • 与3D经会阴系统穿刺活检对照,mpMRI和FCH-PET/CT检测放疗后局部复发敏感度有限但特异度好,前列腺活检仍似为诊断局部复发和筛选局部挽救治疗患者的必要手段。

研究设计与样本

  • 回顾性单中心研究纳入32例疑似前列腺癌复发、已排除转移且3个月内同时接受FCH-PET/CT与3T mpMRI的患者,以系统3D经会阴前列腺穿刺活检为参考标准。
  • 两种影像由2名经验丰富的读片者盲法分析,按患者和4段模型分段进行分析。

主要发现

  • 32例中31例3D经会阴系统穿刺活检证实局部复发。
  • 患者层面检出率mpMRI为71%(22/31),FCH-PET/CT为74%(23/31)。
  • 分段层面敏感度和特异度分别为mpMRI 32%和87%、FCH-PET/CT 34%和87%、两者联合43%和83%。
  • 分段准确率分别为mpMRI 64%、FCH-PET/CT 65%、联合66%。
  • 观察者间一致性FCH-PET/CT为κ=0.92,mpMRI为κ=0.74。

关键数值与推荐

  • 影像检查时中位前列腺特异性抗原(PSA)为2.92 ng/mL,平均PSA倍增时间为14个月。
  • 分段分析采用4段模型,按患者和按段分别计算诊断性能。

临床怎么用

  • FCH-PET/CT和mpMRI可用于提示局部复发,但阴性结果不能排除复发,确诊仍需前列腺穿刺活检。
  • 在筛选可能受益于局部挽救治疗的患者时,应以穿刺活检结果为依据。

局限性

  • 回顾性单中心设计且样本量小(32例),结论需外部验证。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: To compare the diagnostic performance of 18F-fluorocholine positron emission tomography/computed tomography (FCH-PET/CT), multiparametric prostate magnetic resonance imaging (mpMRI), and a combination of both techniques for the detection of local recurrence of prostate cancer initially treated by radiation therapy. METHODS AND MATERIALS: This was a retrospective, single-institution study of 32 patients with suspected prostate cancer recurrence who underwent both FCH-PET/CT and 3T mpMRI within 3 months of one another for the detection of recurrence. All included patients had to be cleared for metastatic recurrence. The reference procedure was systematic 3-dimensional (3D)-transperineal prostate biopsy for the final assessment of local recurrence. Both imaging modalities were analyzed by 2 experienced readers blinded to clinical data. The analysis was made per-patient and per-segment using a 4-segment model. RESULTS: The median prostate-specific antigen value at the time of imaging was 2.92 ng/mL. The mean prostate-specific antigen doubling time was 14 months. Of the 32 patients, 31 had a positive 3D-transperineal mapping biopsy for a local relapse. On a patient-based analysis, the detection rate was 71% (22 of 31) for mpMRI and 74% (23 of 31) for FCH-PET/CT. On a segment-based analysis, the sensitivity and specificity were, respectively, 32% and 87% for mpMRI, 34% and 87% for FCH-PET/CT, and 43% and 83% for the combined analysis of both techniques. Accuracy was 64%, 65%, and 66%, respectively. The interobserver agreement was κ = 0.92 for FCH-PET/CT and κ = 0.74 for mpMRI. CONCLUSIONS: Both mpMRI and FCH-PET/CT show limited sensitivity but good specificity for the detection of local cancer recurrence after radiation therapy, when compared with 3D-transperineal mapping biopsy. Prostate biopsy still seems to be mandatory to diagnose local relapse and select patients who could benefit from local salvage therapy.

来源:Int J Radiat Oncol Biol Phys,查看原文。版权归原作者所有。

引用

  1. Kanoun S, Walker P, Vrigneaud JM, et al. 18F-Choline Positron Emission Tomography/Computed Tomography and Multiparametric Magnetic Resonance Imaging for the Detection of Early Local Recurrence of Prostate Cancer Initially Treated by Radiation Therapy: Comparison With Systematic 3-Dimensional Transperineal Mapping Biopsy. Int J Radiat Oncol Biol Phys. 2016. PMID: 28333020. doi:10.1016/j.ijrobp.2016.12.025

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。